Neurology status update: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Ahmad muneeb (talk | contribs) |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}}; {{AE}} {{Hudakarman}} | {{CMG}}; {{AE}} {{Hudakarman}} | ||
{{Organ System Project}} | {{Organ System Project}} | ||
System leader: '''[[User:Fahimeh Shojaei |Fahimeh Alsadat Shojaei, M.D.]]''' | System leader: '''[[User:Fahimeh Shojaei |Fahimeh Alsadat Shojaei, M.D.]]''' | ||
== Status Updates == | ==Status Updates== | ||
{| border="1" cellpadding="5" cellspacing="0" align="center" | | {| class="wikitable" border="1" cellpadding="5" cellspacing="0" align="center" |class="wikitable" | ||
|+ | |+ | ||
! colspan="2" style="background:#efefef;" | ! colspan="2" style="background:#efefef;" |Resident survival guide Progress | ||
|- | |- | ||
|Completed | |Completed | ||
|9 | |9 | ||
|- | |- | ||
|In progress | |In progress | ||
|8 | |8 | ||
|- | |- | ||
|Remaining | |Remaining | ||
|16 | |16 | ||
|- | |- | ||
! colspan="2" style="background:#efefef;" | ! colspan="2" style="background:#efefef;" |Primary care chapter Progress | ||
|- | |- | ||
|Completed | |Completed | ||
|4 | |4 | ||
|- | |- | ||
|In progress | |In progress | ||
|1 | |1 | ||
|- | |- | ||
|Remaining | |Remaining | ||
|27 | |27 | ||
|} | |} | ||
== Primary Care Topics == | ==Primary Care Topics== | ||
<br /> | <br /> | ||
{| class="wikitable sortable" | {| class="wikitable sortable" | ||
! Specialty | !Specialty | ||
! Topic | !Topic | ||
!Author | |||
!Status | |||
!Resident Survival Guide Page | |||
!Author | !Author | ||
!Status | !Status | ||
|- | |- | ||
| colspan="7" | | | colspan="7" | | ||
===== Symptoms ===== | =====Symptoms===== | ||
|- | |- | ||
| Neurology || [[Altered mental status]] | |Neurology||[[Altered mental status]] | ||
| | | | ||
|Needs content | |Needs content | ||
|[[Altered mental status resident survival guide]]|| Moises||Complete | |[[Altered mental status resident survival guide]]||Moises||Complete | ||
|- | |- | ||
|Neurology | |Neurology | ||
Line 82: | Line 83: | ||
|Remaining | |Remaining | ||
|- | |- | ||
| Neurology || [[Headache]] | |Neurology||[[Headache]] | ||
| | | | ||
|Needs content | |Needs content | ||
Line 112: | Line 113: | ||
|Remaining | |Remaining | ||
|- | |- | ||
| Neurology || [[Seizure]] | |Neurology||[[Seizure]] | ||
| | | | ||
|Needs content | |Needs content | ||
|[[Seizure resident survival guide]]|| Vidit ||In progress | |[[Seizure resident survival guide]]||Vidit||In progress | ||
|- | |- | ||
| Neurology || [[Status epilepticus]] | |Neurology||[[Status epilepticus]] | ||
| | | | ||
|Needs content | |Needs content | ||
|[[Status epilepticus resident survival guide]]|| Vidit ||Complete | |[[Status epilepticus resident survival guide]]||Vidit||Complete | ||
|- | |- | ||
|Neurology | |Neurology | ||
Line 130: | Line 131: | ||
|Remaining | |Remaining | ||
|- | |- | ||
| Neurology ||[[Vertigo]] | |Neurology||[[Vertigo]] | ||
| | | | ||
|Needs content | |Needs content | ||
|[[Vertigo resident survival guide]]|| | |[[Vertigo resident survival guide]]|| ||High priority | ||
|- | |- | ||
| colspan="7" | | | colspan="7" | | ||
===== Disorders ===== | =====Disorders===== | ||
|- | |- | ||
|Neurology | |Neurology | ||
Line 146: | Line 147: | ||
|Remaining | |Remaining | ||
|- | |- | ||
| Neurology ||[[Alcohol withdrawal]] | |Neurology||[[Alcohol withdrawal]] | ||
| | | | ||
|Needs content | |Needs content | ||
|[[Alcohol withdrawal resident survival guide]]||Vidit||Complete | |[[Alcohol withdrawal resident survival guide]]||Vidit||Complete | ||
|- | |- | ||
| Neurology ||[[Back pain]] | |Neurology||[[Back pain]] | ||
| | | | ||
|Needs content | |Needs content | ||
|[[Back pain resident survival guide]]|| Hilda ||Remaining | |[[Back pain resident survival guide]]||Hilda||Remaining | ||
|- | |- | ||
|Neurology | |Neurology | ||
Line 228: | Line 229: | ||
|Compelete | |Compelete | ||
|- | |- | ||
| Neurology ||[[Opioid]] | |Neurology||[[Opioid]] | ||
| | | | ||
|Needs content | |Needs content | ||
|[[Opioid resident survival guide]]|| Vidit ||In progress | |[[Opioid resident survival guide]]||Vidit||In progress | ||
|- | |- | ||
| Neurology ||[[Opioid overdose]] | |Neurology||[[Opioid overdose]] | ||
| | | | ||
|Needs review | |Needs review | ||
|[[Opioid overdose resident survival guide]]|| Vidit ||In progress | |[[Opioid overdose resident survival guide]]||Vidit||In progress | ||
|- | |- | ||
| Neurology ||[[Opioid withdrawal]] | |Neurology||[[Opioid withdrawal]] | ||
| | | | ||
|Needs content | |Needs content | ||
|[[Opioid withdrawal resident survival guide]]|| Vidit ||In progress | |[[Opioid withdrawal resident survival guide]]||Vidit||In progress | ||
|- | |- | ||
|Neurology | |Neurology | ||
Line 259: | Line 260: | ||
|Remaining | |Remaining | ||
|- | |- | ||
| Neurology ||[[Stroke]] | |Neurology||[[Stroke]] | ||
| | | | ||
|Needs review | |Needs review | ||
|[[Stroke resident survival guide]]|| Ayokunle ||In progress | |[[Stroke resident survival guide]]||Ayokunle||In progress | ||
|- | |- | ||
|Neurology | |Neurology | ||
Line 282: | Line 283: | ||
==Status Update== | ==Status Update== | ||
{| border="1" cellpadding="5" cellspacing="0" align="center" | | {| class="wikitable" border="1" cellpadding="5" cellspacing="0" align="center" |class="wikitable" | ||
|+ | |+ | ||
! colspan="2" style="background:#efefef;" | ! colspan="2" style="background:#efefef;" |Progress | ||
|- | |- | ||
|Completed | |Completed | ||
| | | | ||
|- | |- | ||
|In progress | |In progress | ||
| | | | ||
|- | |- | ||
|Remaining | |Remaining | ||
| | | | ||
|} | |} | ||
== Chapters requiring content == | ==Chapters requiring content== | ||
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center | {| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | ||
! style="background: #4479BA; padding: 5px 5px;" | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Category}} | ||
! style="background: #4479BA; padding: 5px 5px;" | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Chapters that need content}} | ||
! style="background: #4479BA; padding: 5px 5px;" | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Assignment Status}} | ||
! style="background: #4479BA; padding: 5px 5px;" | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Scholar's name}} | ||
! style="background: #4479BA; padding: 5px 5px;" | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Coach name}} | ||
! style="background: #4479BA; padding: 5px 5px;" | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Completion Status}} | ||
! style="background: #4479BA; padding: 5px 5px;" | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Review status}} | ||
! style="background: #4479BA; padding: 5px 5px;" | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Reviewer name}} | ||
|- | |- | ||
| rowspan="60" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Neurology | | rowspan="60" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Neurology | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Alternating hemiplegia | | style="padding: 5px 5px; background: #F5F5F5;" |Alternating hemiplegia | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 316: | Line 317: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Amyotrophic lateral sclerosis | | style="padding: 5px 5px; background: #F5F5F5;" |Amyotrophic lateral sclerosis | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 325: | Line 326: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Aneurysm (landing page) | | style="padding: 5px 5px; background: #F5F5F5;" |Aneurysm (landing page) | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 332: | Line 333: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Aphasia Landing page | | style="padding: 5px 5px; background: #F5F5F5;" |Aphasia Landing page | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 373: | Line 374: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Benign focal amyotrophy | | style="padding: 5px 5px; background: #F5F5F5;" |Benign focal amyotrophy | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 381: | Line 382: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Bitemporal hemianopia | | style="padding: 5px 5px; background: #F5F5F5;" |Bitemporal hemianopia | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 389: | Line 390: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Brachial plexus injuries | | style="padding: 5px 5px; background: #F5F5F5;" |Brachial plexus injuries | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 405: | Line 406: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Brown-Sequard syndrome | | style="padding: 5px 5px; background: #F5F5F5;" |Brown-Sequard syndrome | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |ahmad muneeb | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 429: | Line 430: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |CN II | | style="padding: 5px 5px; background: #F5F5F5;" |CN II | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 437: | Line 438: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |CN III | | style="padding: 5px 5px; background: #F5F5F5;" |CN III | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 445: | Line 446: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |CN IV | | style="padding: 5px 5px; background: #F5F5F5;" |CN IV | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 453: | Line 454: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |CN V | | style="padding: 5px 5px; background: #F5F5F5;" |CN V | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 461: | Line 462: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |CN VI | | style="padding: 5px 5px; background: #F5F5F5;" |CN VI | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 468: | Line 469: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | CN VII | | style="padding: 5px 5px; background: #F5F5F5;" |CN VII | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 477: | Line 478: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |CN VIII | | style="padding: 5px 5px; background: #F5F5F5;" |CN VIII | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 485: | Line 486: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |CN IX | | style="padding: 5px 5px; background: #F5F5F5;" |CN IX | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 493: | Line 494: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |CN X | | style="padding: 5px 5px; background: #F5F5F5;" |CN X | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 501: | Line 502: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |CN XI | | style="padding: 5px 5px; background: #F5F5F5;" |CN XI | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 509: | Line 510: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |CN XII | | style="padding: 5px 5px; background: #F5F5F5;" |CN XII | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 516: | Line 517: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Causalgia | | style="padding: 5px 5px; background: #F5F5F5;" |Causalgia | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 525: | Line 526: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Cerebral arteriosclerosis | | style="padding: 5px 5px; background: #F5F5F5;" |Cerebral arteriosclerosis | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 533: | Line 534: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Cerebellar degeneration | | style="padding: 5px 5px; background: #F5F5F5;" |Cerebellar degeneration | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 541: | Line 542: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Cerebellar hypoplasia | | style="padding: 5px 5px; background: #F5F5F5;" |Cerebellar hypoplasia | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |ahmad muneeb | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 549: | Line 550: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Chronic inflamatory demyelinating polyneuropathy | | style="padding: 5px 5px; background: #F5F5F5;" |Chronic inflamatory demyelinating polyneuropathy | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 564: | Line 565: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Conductive Aphasia | | style="padding: 5px 5px; background: #F5F5F5;" |Conductive Aphasia | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 580: | Line 581: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Congenital myasthenia | | style="padding: 5px 5px; background: #F5F5F5;" |Congenital myasthenia | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 589: | Line 590: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Congenital myopathy | | style="padding: 5px 5px; background: #F5F5F5;" |Congenital myopathy | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 597: | Line 598: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Corticobasal degeneration | | style="padding: 5px 5px; background: #F5F5F5;" |Corticobasal degeneration | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 604: | Line 605: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Dementia landing page | | style="padding: 5px 5px; background: #F5F5F5;" |Dementia landing page | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 613: | Line 614: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Disc slip/herniation | | style="padding: 5px 5px; background: #F5F5F5;" |Disc slip/herniation | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 620: | Line 621: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Dysautonomia | | style="padding: 5px 5px; background: #F5F5F5;" |Dysautonomia | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 637: | Line 638: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Guillian-Barre syndrome | | style="padding: 5px 5px; background: #F5F5F5;" |Guillian-Barre syndrome | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 661: | Line 662: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Inflammatory myopathies | | style="padding: 5px 5px; background: #F5F5F5;" |Inflammatory myopathies | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 669: | Line 670: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Intracranial cysts | | style="padding: 5px 5px; background: #F5F5F5;" |Intracranial cysts | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 677: | Line 678: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Intracranial hypertension | | style="padding: 5px 5px; background: #F5F5F5;" |Intracranial hypertension | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 684: | Line 685: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Ischemic stroke | | style="padding: 5px 5px; background: #F5F5F5;" |Ischemic stroke | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 692: | Line 693: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Lewy body dementia | | style="padding: 5px 5px; background: #F5F5F5;" |Lewy body dementia | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 701: | Line 702: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Muscle dystrophy (LP) | | style="padding: 5px 5px; background: #F5F5F5;" |Muscle dystrophy (LP) | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 709: | Line 710: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Myopathies | | style="padding: 5px 5px; background: #F5F5F5;" |Myopathies | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 716: | Line 717: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Peripheral Neuropathy | | style="padding: 5px 5px; background: #F5F5F5;" |Peripheral Neuropathy | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 724: | Line 725: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Spinal tumors (LP) | | style="padding: 5px 5px; background: #F5F5F5;" |Spinal tumors (LP) | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 748: | Line 749: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Tinnitus | | style="padding: 5px 5px; background: #F5F5F5;" |Tinnitus | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 757: | Line 758: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Tourette syndrome | | style="padding: 5px 5px; background: #F5F5F5;" |Tourette syndrome | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 765: | Line 766: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Traumatic brain injury | | style="padding: 5px 5px; background: #F5F5F5;" |Traumatic brain injury | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 782: | Line 783: | ||
|} | |} | ||
== In progress chapters == | ==In progress chapters== | ||
Line 1,217: | Line 1,218: | ||
|} | |} | ||
== Completed chapters == | ==Completed chapters== | ||
Revision as of 06:51, 26 August 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Huda A. Karman, M.D.
Organ System Project |
---|
Topics |
Leaders & Members |
Meetings' Summary |
System leader: Fahimeh Alsadat Shojaei, M.D.
Status Updates
Resident survival guide Progress | |
---|---|
Completed | 9 |
In progress | 8 |
Remaining | 16 |
Primary care chapter Progress | |
Completed | 4 |
In progress | 1 |
Remaining | 27 |
Primary Care Topics
Status Update
Progress | |
---|---|
Completed | |
In progress | |
Remaining |
Chapters requiring content
Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
---|---|---|---|---|---|---|---|
Neurology | |||||||
Alternating hemiplegia | |||||||
Amyotrophic lateral sclerosis | |||||||
Aneurysm (landing page) | |||||||
Aphasia Landing page | |||||||
Acute disseminated encephalomyelitis | |||||||
Adie's syndrome | |||||||
Agenesis of the corpus callosum (ACC) | |||||||
Ataxi telangectasia | |||||||
Benign focal amyotrophy | |||||||
Bitemporal hemianopia | |||||||
Brachial plexus injuries | |||||||
Brain tumors (LP) | |||||||
Brown-Sequard syndrome | ahmad muneeb | ||||||
Blepharospasm | |||||||
Cranial nerve function & injuries(LP) | |||||||
CN II | |||||||
CN III | |||||||
CN IV | |||||||
CN V | |||||||
CN VI | |||||||
CN VII | |||||||
CN VIII | |||||||
CN IX | |||||||
CN X | |||||||
CN XI | |||||||
CN XII | |||||||
Causalgia | |||||||
Cerebral arteriosclerosis | |||||||
Cerebellar degeneration | |||||||
Cerebellar hypoplasia | ahmad muneeb | ||||||
Chronic inflamatory demyelinating polyneuropathy | |||||||
Concussion | |||||||
Conductive Aphasia | |||||||
Coma and vegetative state | |||||||
Congenital myasthenia | |||||||
Congenital myopathy | |||||||
Corticobasal degeneration | |||||||
Dementia landing page | |||||||
Disc slip/herniation | |||||||
Dysautonomia | |||||||
Gait disorders(LP) | |||||||
Guillian-Barre syndrome | |||||||
Headache landing page | |||||||
Hemorrhagic stroke | |||||||
Inflammatory myopathies | |||||||
Intracranial cysts | |||||||
Intracranial hypertension | |||||||
Ischemic stroke | |||||||
Lewy body dementia | |||||||
Muscle dystrophy (LP) | |||||||
Myopathies | |||||||
Peripheral Neuropathy | |||||||
Spinal tumors (LP) | |||||||
Subarachanoid hemorrhage | |||||||
Tabes dorsalis | |||||||
Tinnitus | |||||||
Tourette syndrome | |||||||
Traumatic brain injury | |||||||
Tremor |
In progress chapters
Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
---|---|---|---|---|---|---|---|
Neurology | Anencephaly | assigned | Ayesha Farheen Javid | Sogand | In progress | ||
Ataxia telangiectasia | assigned | Niloofar | In progress | ||||
Adrenoleukodystrophy | assigned | Ibtisam | Sahar | Compelete | In progress | ||
Angelman syndrome | assigned | Moises | Fahimeh | Complete | In progress | ||
Apraxia | assigned | Parul | Sahar | In progress | |||
Arachnoid cyst | assigned | Jose | Sahar | Compelete | In progress | ||
Arachnoiditis | assigned | Qasim Khurshid | Maneesha | Complete | In progress | Maneesha | |
Asperger syndrome | assigned | Shakiba Hassanzadeh | Ahmed elsaiey | In progress | |||
Ataxia | assigned | Apeshka gupta | Aditya | In progress | |||
Autonomic dysfunction | assigned | Atif | Mosadegh | In progress | |||
Aicardi syndrome | assigned | Moises | Fahime | In progress | |||
Alexander disease | assigned | Moises | Fahime | compelete | |||
Alpers disease | assigned | Zehra Melik | Sahar | In progress | |||
Becker muscular dystrophy | assigned | Moises Romo | Fahimeh | Compelete | In progress | ||
Benign essential blepharospasm | assigned | Ibtisam | Sahar | In progress | |||
Brain hemorrhage (LP) | assigned | Fahimeh | In progress | ||||
Broca/Global Aphasia | assigned | Anoze | Aditya | In progress | |||
Brachial plexus injuries | assigned | Vidhi | Amandeep | In progress | |||
Brain herniation | assigned | Parul | Sahar | In progress | |||
CN I | assigned | Behzad | Farima | In progress | |||
Central cord syndrome | assigned | Abdulkareem | Sahar | In progress | |||
Central pontine myelinolysis | assigned | Dara | |||||
Cerebral Aneurysm | assigned | Harmeet | Amandeep | In progress | |||
Creutzfeldt-Jakob disease | assigned | Dara/ Twinkle | Complete | In progress | Mosadegh | ||
Cluster headache | assigned | Sabeeh | Aditya | In progress | |||
Dancing eye dancing feet syndrome | assigned | Jose | Sahar | In progress | |||
Dandy Walker syndrome | assigned | Zehra Malik | Sahar | Compelete | In progress | ||
Dyslexia | assigned | Madona | Aditya | In progress | |||
Dystonia | assigned | Shadi | Fahimeh | In progress | |||
Encephalopathy | assigned | Kanwal Khamuani | Farima | In progress | |||
Erb's palsy | assigned | Moises Romo | Fahimeh | Complete | In progress | ||
Essential tremor | assigned | Rina Ghorpade | Maneesha | In progress | |||
Frontotemporal dementia | Assigned | Qasim Khurshid | Maneesha | ||||
Gerstman syndrome | assigned | Saketh | Fahimeh | In progress | |||
Intraparenchymal hemorrhage (SP) | assigned | Ahmad | Fahimeh | In progress | |||
Infantile spasms | assigned | kanwal | Farima | In progress | |||
Lambert Eaton syndrome | assigned | Indhumathi | Maneesha | In progress | |||
Lateral medullary syndrome | assigned | Sabeeh Islam, MBBS[2] | Aditya Ganti M.B.B.S. [3] | Completed | In progress | Aditya Ganti M.B.B.S. [4] | |
Narcolepsy | assigned | Waleed | Homa | In progress | |||
Neurofibromatosis I | assigned | Moises | Fahimeh | Complete | In progress | ||
Neurofibromatosis II | assigned | Moises | Fahimeh | In progress | |||
Neuroleptic malignant syndrome | Assigned | Qasim khurshid | Maneesha | ||||
Pick's disease | assigned | Shadi ebr | Sahar | In progress | |||
Polio | assigned | Gurman | Amandeeo | In progress | |||
Prion disease | assigned | Waleed | Homa | In progress | |||
Sturge-Weber syndrome | assigned | Rina ghorpade | Maneesha | Complete | In progress | Maneesha | |
Syringomyelia | assigned | Eman | Huda | In progress | |||
Tension headache | assigned | Sabeeh Islam, MBBS[5] | Aditya Ganti M.B.B.S. [6] | Completed | In Progress | Aditya Ganti M.B.B.S. [7] | |
Tuberous sclerosis | assigned | Jose | Sahar | Complete | In progress | ||
Alexander disease | assigned | Moises | Fahimeh | Complete | |||
Aicardi syndrome | assigned | Moises | Fahimeh | In progress |
Completed chapters
Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
---|---|---|---|---|---|---|---|
Neurology | CN VII | Assigned | Dara | ||||
Dandy Walker syndrome | Assigned | Zehra Malik | Sahar | Complete | |||
Duchenne muscle dystrophy | Assigned | Fahimeh | compelete | compelete | |||
Parkinsons Disease | Assigned | Fahimeh | compelete | compelete | Sogand | ||
Epilepsy | Assigned | Fahimeh | compelete | compelete | Farima | ||
Multiple sclerosis | Assigned | Fahimeh | compelete | compelete | Khurram | ||
Myasthenia gravis | Assigned | Fahimeh | compelete | complete | Sogand | ||
Subdural hemorrhage | Assigned | Fahimeh | compelete | complete | Sogand | ||
GB syndrome | Assigned | Fahimeh | compelete | complete | Sogand | ||
Bell's palsy | Assigned | Dara | compelete | complete | Niloofar | ||
Spina bifida | Assigned | Dara | compelete | complete | Sadaf | ||
Autism | assigned | Aditya | compelete | ||||
Canavan disease | Assigned | Zehra Malik | Complete | In progress | |||